ProcureCon Pharma US 2018

October 22 - 23, 2018

The Westin Princeton at Forrestal Village, NJ

Contact Us: 1.888.482.6012

Whitepaper & Video Center

Procurement’s Impact on Pharma in 2016

After several months of market research, we found that many pharma companies lag behind their peers when it comes to modernizing the  procurement function.  In our report titled, “Procurement’s impact on pharma”, you’ll see some of the ways pharma companies are looking beyond 2016 to transform their procurement teams. Download today - by click the image on the left!

Advantages of an Integrated MSP and VMS Approach

Sourcing the right talent is becoming a competitive differentiator for many companies. Teams with top talent outperform those with average talent by a factor of 5x to 10x. Also, with contingent labor comprising more than 20 percent of the total workforce, how that labor is sourced and managed suddenly plays a critical role. It takes a combined services and technology approach. This eBook explores the options that are available to enterprises and maps out the reasons why an integrated Managed Service Provider (MSP) and Vendor Management System (VMS) approach is more effective than one where separate vendors are responsible for the MSP and VMS components. The examination explores six operational areas and three business outcomes where an integrated approach proves advantageous.

Approaching Accountable Care Organizations and Integrated Delivery Networks in the Post-Reform Era

Despite being the highest spender on health care in the world and paying approximately 17% of its GDP on health care, the United States still has poor population health and worse outcomes than its international peers. As a result of this unsustainable spending in the US health care sector, health care reform has prompted a number of alternative care and payment models, and prompted the revitalization of others. Among these new and resurrected approaches are accountable care organizations (ACOs) and integrated delivery networks (IDNs). Regardless of the customer—ACO or IDN—pharma needs to act now as consolidation does not look to be slowing down. Manufacturers aiming to forge lasting partnerships will need to critically assess this evolving segment and offer solutions to the organizations that create value by addressing the Triple Aim.

Three Steps to an Effective Asset Management Program for Your Surplus Laboratory Equipment

Consider these real-life scenarios in the biopharmaceuticals industry: A pharmaceutical company plans to close one of its research campuses, leaving millions of dollars in assets that need to be redeployed or sold. An organization has completed a project and no longer needs various assets, including several large capital assets and standard lab equipment. A large pharmaceutical company purchases the newest research devices to keep up with technological advancements, leaving a surplus of older models still in good working condition. These and many other situations can result in surplus biopharmaceutical equipment that is no longer required in the same capacity – or at all. With budgets tight and sustainable business practices a must, your organization shouldn’t let this surplus lie idle. Surplus asset management requires an innovative, sustainable process that supports strategic business goals. In this white paper, you will learn the three steps to developing an effective surplus management program in the biopharmaceuticals industry.

ProcureCon Pharma Attendee List

Who will you meet at ProcureCon Pharma? Download our attendee list to take a quick look! The Online Marketplace for Scientific Research Services

Founded in 2007, is the world’s largest and fastest-growing marketplace for outsourced research services and products. For the past ten years, the San Diego-based company has made it easy for scientists to connect with technical experts at over 17,700 global contract research organizations (CROs) and academic core facilities. The marketplace covers 3,626 research areas across multiple industries (pharma, biotech, crop science, animal health, cosmetics and consumer health) and scientific disciplines (biology, chemistry, toxicology, metabolism, etc.).

Want even more reading material? View whitepapers and reports from our 2017 event.

2017 Media Center